X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4997) 4997
Publication (338) 338
Book Review (55) 55
Magazine Article (18) 18
Newsletter (13) 13
Book Chapter (4) 4
Newspaper Article (3) 3
Data Set (2) 2
Dissertation (1) 1
Paper (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (4209) 4209
pravastatin (3502) 3502
male (2845) 2845
female (2491) 2491
middle aged (2198) 2198
hydroxymethylglutaryl-coa reductase inhibitors - therapeutic use (2048) 2048
pravastatin - therapeutic use (1785) 1785
aged (1667) 1667
statins (1516) 1516
index medicus (1404) 1404
anticholesteremic agents - therapeutic use (1344) 1344
cholesterol (1263) 1263
adult (1180) 1180
simvastatin (1180) 1180
cardiac & cardiovascular systems (1153) 1153
pharmacology & pharmacy (1110) 1110
atorvastatin (1031) 1031
cholesterol, ldl - blood (953) 953
hypercholesterolemia - drug therapy (948) 948
risk factors (945) 945
prevention (940) 940
treatment outcome (909) 909
risk (763) 763
hypercholesterolemia (717) 717
cholesterol - blood (705) 705
coronary-heart-disease (692) 692
atherosclerosis (660) 660
animals (654) 654
heptanoic acids - therapeutic use (603) 603
myocardial-infarction (599) 599
events (592) 592
medicine, general & internal (591) 591
peripheral vascular disease (574) 574
simvastatin - therapeutic use (556) 556
pyrroles - therapeutic use (547) 547
atorvastatin calcium (529) 529
men (529) 529
hydroxymethylglutaryl-coa reductase inhibitors - pharmacology (501) 501
double-blind method (497) 497
therapy (475) 475
mortality (460) 460
lovastatin (455) 455
pravastatin - pharmacology (439) 439
hypolipidemic agents - therapeutic use (438) 438
coronary disease - prevention & control (434) 434
disease (430) 430
triglycerides - blood (426) 426
hydroxymethylglutaryl-coa reductase inhibitors - adverse effects (415) 415
hypercholesterolemia - blood (410) 410
cholesterol, hdl - blood (404) 404
randomized controlled trials as topic (402) 402
prospective studies (401) 401
lipids (399) 399
drug therapy (394) 394
lipids - blood (388) 388
hyperlipidemias - drug therapy (386) 386
follow-up studies (384) 384
time factors (372) 372
cardiovascular diseases - prevention & control (362) 362
hydroxymethylglutaryl-coa reductase inhibitors - administration & dosage (362) 362
aged, 80 and over (351) 351
analysis (351) 351
statin (349) 349
coronary heart disease (336) 336
c-reactive protein (332) 332
cardiovascular disease (332) 332
heart-disease (325) 325
rosuvastatin (323) 323
efficacy (315) 315
inflammation (313) 313
antilipemic agents (306) 306
drug therapy, combination (305) 305
primary prevention (297) 297
cardiovascular-disease (296) 296
coa reductase inhibitors (295) 295
retrospective studies (291) 291
lovastatin - therapeutic use (290) 290
dose-response relationship, drug (287) 287
coronary disease - drug therapy (286) 286
pravastatin - administration & dosage (284) 284
clinical trials as topic (280) 280
research (277) 277
safety (277) 277
fluvastatin (274) 274
cardiovascular agents (272) 272
care and treatment (270) 270
hypercholesterolemia - complications (267) 267
pravastatin - adverse effects (248) 248
rosuvastatin calcium (247) 247
medicine & public health (242) 242
low density lipoproteins (241) 241
cardiovascular diseases (239) 239
anticholesteremic agents - pharmacology (237) 237
rats (237) 237
coronary heart-disease (222) 222
health aspects (220) 220
cholesterol levels (218) 218
drug interactions (217) 217
endocrinology & metabolism (216) 216
cohort studies (215) 215
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4757) 4757
German (65) 65
French (45) 45
Spanish (44) 44
Russian (30) 30
Japanese (27) 27
Italian (22) 22
Chinese (14) 14
Portuguese (12) 12
Norwegian (4) 4
Czech (3) 3
Dutch (3) 3
Danish (2) 2
Serbian (2) 2
Finnish (1) 1
Hungarian (1) 1
Polish (1) 1
Swedish (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Circulation, ISSN 0009-7322, 08/2004, Volume 110, Issue 9, pp. 1061 - 1068
Journal Article
Arteriosclerosis, Thrombosis, and Vascular Biology, ISSN 1079-5642, 01/2015, Volume 35, Issue 4, pp. 981 - 989
Journal Article
International Journal of Cancer, ISSN 0020-7136, 09/2008, Volume 123, Issue 5, pp. 983 - 990
Statins and nonsteroidal antiinflammatory drugs (NSAIDs) are commonly prescribed for lowering cholesterol and antiinflammation, respectively. Recently, their... 
cancer chemoprevention | statins | NSAIDs | Cancer chemoprevention | Statins | CELECOXIB INDUCES APOPTOSIS | HUMAN LUNG-CANCER | SELECTIVE COX-2 INHIBITORS | PREVENT COLORECTAL ADENOMAS | COLON-CANCER | ONCOLOGY | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | CHOLESTEROL-LOWERING DRUGS | FAMILIAL ADENOMATOUS POLYPOSIS | NF-KAPPA-B | ENDOTHELIAL GROWTH-FACTOR | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - therapeutic use | Meta-Analysis as Topic | Pyrazoles - therapeutic use | Heptanoic Acids - therapeutic use | Humans | Neoplasms - prevention & control | Anti-Inflammatory Agents, Non-Steroidal - pharmacology | Fatty Acids, Monounsaturated - therapeutic use | Anticarcinogenic Agents - administration & dosage | Aspirin - therapeutic use | Drug Therapy, Combination | Pyrroles - therapeutic use | Anticarcinogenic Agents - pharmacology | Pravastatin - therapeutic use | Anticarcinogenic Agents - therapeutic use | Pyridines - therapeutic use | Lovastatin - therapeutic use | Drug Administration Schedule | Colorectal Neoplasms - prevention & control | Celecoxib | Sulindac - therapeutic use | Evidence-Based Medicine | Randomized Controlled Trials as Topic | Drug Synergism | Atorvastatin Calcium | Animals | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Sulfonamides - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Anti-Inflammatory Agents, Non-Steroidal - administration & dosage | Indoles - therapeutic use | Index Medicus
Journal Article
Journal Article
Thrombosis and Haemostasis, ISSN 0340-6245, 2016, Volume 115, Issue 3, pp. 520 - 532
Journal Article
Journal of Vascular Surgery, ISSN 0741-5214, 2005, Volume 41, Issue 4, pp. 733 - 733
BACKGROUND: Statins lower the levels of low-density lipoprotein (LDL) cholesterol and C-reactive protein (CRP). Whether this latter property affects clinical... 
MEDICINE, GENERAL & INTERNAL | DENSITY-LIPOPROTEIN CHOLESTEROL | INFLAMMATION | CARDIOVASCULAR-DISEASE | MARKERS | RISK | ACUTE CORONARY SYNDROMES | PRAVASTATIN | PRIMARY PREVENTION | PREDICTION | ATORVASTATIN | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Myocardial Infarction - blood | Heptanoic Acids - therapeutic use | Humans | Middle Aged | Male | Secondary Prevention | Coronary Disease - mortality | Incidence | C-Reactive Protein - metabolism | Pyrroles - administration & dosage | Heptanoic Acids - administration & dosage | Cholesterol, LDL - blood | Female | C-Reactive Protein - drug effects | Pyrroles - therapeutic use | Pravastatin - therapeutic use | Heptanoic Acids - pharmacology | Pravastatin - pharmacology | Coronary Disease - blood | Risk Factors | Proportional Hazards Models | Cholesterol, LDL - drug effects | Fluoroquinolones - therapeutic use | Biomarkers - blood | Atorvastatin Calcium | Coronary Disease - prevention & control | Pyrroles - pharmacology | Anticholesteremic Agents - therapeutic use | Hydroxymethylglutaryl-CoA Reductase Inhibitors - pharmacology | Myocardial Infarction - drug therapy | Pravastatin - administration & dosage | Anticholesteremic Agents - administration & dosage | Hydroxymethylglutaryl-CoA Reductase Inhibitors - therapeutic use | Myocardial Infarction - prevention & control | Anticholesteremic Agents - pharmacology | Cardiovascular disease | Heart attacks | Cholesterol | Statins
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 01/2005, Volume 352, Issue 1, pp. 20 - 28
Statin therapy lowers not only low-density lipoprotein (LDL) cholesterol levels, but also levels of C-reactive protein (CRP), a marker of inflammation. This... 
Journal Article